Delivery Order SPE2DR25D2104-SPE2DR26F3QYF
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $23,464.63 to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count supply) with an ultimate completion date of July 1, 2025. This firm fixed-price, non-set-aside contract represents a single delivery under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets (30-count) valued at $6,451.32 under firm fixed price terms. This non-set-aside, competitively awarded delivery order has an ultimate completion date of November 28, 2025, and represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,337.61 to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count) on November 18, 2025, with completion expected by November 19, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $19,710.72 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets in a 30-count package. The contract was competitively awarded without set-aside designation on May 27, 2025, with a completion date of May 28, 2025. This delivery order operates under a firm fixed-price arrangement and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for REXULTI 3 MG tablets (30-count supply) with a ceiling value of $22,083.84. This firm fixed price delivery order represents a non-competitive set-aside contract and is scheduled for ultimate completion by August 8, 2025. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for REXULTI 3 mg tablets (30-count packaging) with a ceiling value of $2,928.63 under a firm fixed price contract type. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and was executed without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,290.83 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets (30-count packaging) under a firm fixed price contract. This non-set-aside delivery order, awarded on June 2, 2025, with completion scheduled for June 3, 2025, will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,259.26 for REXULTI 0.5 mg tablets (30-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) leverages AmerisourceBergen's position as a prime vendor under the DLA Troop Support Medical Indefinite Delivery Contract SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,935.15 to AmerisourceBergen Drug Corp for supply of REXULTI 0.5 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement. Performance will be executed from the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,620.81 to AmerisourceBergen Drug Corp for the supply of REXULTI 2 mg tablets (30-count packaging) with a firm fixed price and an ultimate completion date of September 11, 2025. This non-set-aside competitive award was issued on September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026....